^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

PM1080

i
Associations
Company:
BioNTech, Jiangsu Hansoh Pharma
Drug class:
EGFR inhibitor, c-MET inhibitor
Related drugs:
Associations
17d
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors (clinicaltrials.gov)
P1, N=780, Recruiting, Hansoh BioMedical R&D Company | Not yet recruiting --> Recruiting
Enrollment open
|
BRAF (B-raf proto-oncogene)
|
cisplatin • carboplatin • 5-fluorouracil • capecitabine • oxaliplatin • irinotecan • leucovorin calcium • GSK5764227 • PM1080
7ms
New P1 trial
|
BRAF (B-raf proto-oncogene)
|
cisplatin • carboplatin • 5-fluorouracil • GSK5764227 • PM1080
12ms
New P2/3 trial • Metastases
|
Ameile (aumolertinib) • PM1080
almost2years
New P1 trial • Metastases
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 20 insertion • EGFR exon 20 mutation
|
PM1080